Pictet Asset Management (Switzerland)’s Meridian Bioscience Inc VIVO Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,298	Closed	-$209K	–	2066
2022 Q4	$209K	Buy	+6,298	New	+$203K	﹤0.01%	1718

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s VIVO Position: Q1 2023 in Review

Pictet Asset Management (Switzerland) sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,298 shares — an estimated $209K sold.

Pictet Asset Management (Switzerland) first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $209K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Pictet Asset Management (Switzerland) reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Pictet Asset Management (Switzerland) sold 6,298 Meridian Bioscience Inc shares in Q1 2023, an estimated $209K.
Pictet Asset Management (Switzerland) first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Pictet Asset Management (Switzerland)'s Meridian Bioscience Inc position peaked at $209K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q1 2023, filed 10 May 2023.